U.S. Clinical Decision Support Systems Market

U.S. Clinical Decision Support Systems Market Size (2023 to 2028)

The size of the U.S. CDSS market is forecasted to be growing at a significant CAGR from 2023 to 2028.

The growing need to reduce human errors, the rising demand to reduce healthcare expenditures, the need to improve healthcare quality, the growing chronic disease population are some of the primary factors that are likely to fuel the U.S. clinical decision support systems market's growth during the forecast period. The CDSS includes several tools that aid in clinical workflow decision-making. It serves as a technological double-check for physicians as they execute the difficult task of effectively assessing, diagnosing, and treating patients. The rising prevalence of pharmaceutical errors and government laws and initiatives to encourage the adoption of Healthcare IT solutions, the increasing acceptance of CDSS-enabled EHRs, and the rising frequency of pharmaceutical mistakes are all driving the expansion of the CDSS market in the United States.

The market is also further driven by the increasing use of information systems by hospitals and healthcare institutions, the growing need for high-quality care and integrated, dependable technical solutions, and favorable efforts implemented by several governments worldwide. A crucial aspect driving market expansion is the increasing usage of mHealth solutions. Clinical decision support systems users of mobile health allow for patient monitoring, symptom variations, and medication adherence to detect changes in medication courses. The government rules for EHR for preserving records on medical diagnostic procedures related to the patient and its medical history have also contributed to market expansion. In the United States, the government creates standards and rules for keeping medical records.

Lack of trust in the system, which is still in its early stages of development, and a lack of skilled labor and CDSS recommendations for superfluous diagnostic tests, may hinder the market growth. During the forecast period, the high investment required for CDSS installation and a lack of interoperability and data security concerns are projected to limit the market's growth.

COVID-19 Impact on U.S. CDSS Market:

Medical practices of all kinds are under enormous pressure due to the COVID-19 epidemic, and healthcare institutions throughout the world have been overwhelmed by the high number of patients who see them regularly. Furthermore, due to the disease's fast spread worldwide, hospital beds and healthcare staff are in short supply. A clinical decision support system (CDSS) is a healthcare information technology system meant to help healthcare professionals and physicians make clinical decisions. Clinical decision support systems have proved to be quite useful since they enable healthcare providers to monitor patients using digitally connected non-invasive equipment like home blood pressure monitors and pulse oximeters.

This research report on the U.S. CDSS market has been segmented and sub-segmented into the following categories.

By Component:

• Hardware
• Software
• Services

By Delivery Mode:

• Cloud-based
• On-premise

By Product:

• Standalone CDSS
• Integrated CDSS

By Type:

• Therapeutic CDSS
• Diagnostic CDSS

By Model:

• Knowledge-based CDSS
• Non-Knowledge-based CDSS

By User Interactivity:

• Active CDSS
• Passive CDSS

By Application:

• Conventional CDSS
• Advanced CDSS

By Setting:

• Inpatient Settings
• Ambulatory Care Settings

By Country:

• The United States

The global clinical decision support systems market is likely to be dominated by the United States. This region's highly established and technologically advanced treatment and research framework for disease diagnostics are driving this growth. Furthermore, the availability of advantageous reimbursement policies is assisting the American market is expanding at a rapid rate. The regional market is likely to be propelled by rising demand for healthcare information technology solutions in the medical sector and an increasing emphasis on high-quality healthcare services. Because of many key businesses in the region, the technical advancement in the healthcare industry in the U.S. has progressed steadily, resulting in the availability of various progressive models of clinical decision support systems. The rising cost of healthcare in the region is expected to drive the market for clinical decision support systems in the area even further.

KEY MARKET PARTICIPANTS:

Wolters Kluwer Health (USA), Hearst Health (USA), and Elsevier B.V., Cerner Corporation (USA), McKesson Corporation (USA), Epic Systems Corporation (USA), MEDITECH (USA), Philips Healthcare, and International Business Machines (IBM) (USA), and Allscripts Healthcare Solutions, Inc. (USA) are a few of the leading companies in the U.S. clinical support decision systems market.